+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Consumer Health in Australia

  • PDF Icon

    Report

  • 118 Pages
  • October 2021
  • Region: Australia
  • Euromonitor International
  • ID: 2510019
Consumer health is set to register yet another year of solid current value growth in 2021, following impressive growth rates witnessed the previous year due to the outbreak of the COVID-19 pandemic in Australia. The latter has been disruptive to consumer health and exposed health vulnerabilities of local consumers, especially those who are at greater risk of developing more serious illnesses from the virus.

The publisher's Consumer Health in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:


Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage:


Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?


  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

EXECUTIVE SUMMARY
  • Consumer health in 2021: The big picture
  • 2021 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
  • Table 2 Life Expectancy at Birth 2016-2021

MARKET DATA
  • Table 3 Sales of Consumer Health by Category: Value 2016-2021
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
  • Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
  • Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026

APPENDIX
OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2020-2021

DISCLAIMERDEFINITIONS
SOURCES
  • Summary 2 Research Sources

ANALGESICS IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Strong demand for analgesics during pandemic continues to drive value sales in 2021

GSK Consumer Healthcare retains overall leadership of analgesics
  • Reckitt Benckiser remains strongest competitor to GSK Consumer Healthcare in 2021

PROSPECTS AND OPPORTUNITIES
  • Increase in elderly population suffering from chronic illnesses to support growth of analgesics over the forecast period
  • Solid demand for trusted analgesics in terms of efficacy
  • New entry intends to disrupt the competitive landscape

CATEGORY DATA
  • Table 12 Sales of Analgesics by Category: Value 2016-2021
  • Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
  • Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
  • Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
  • Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
  • Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Cold, cough and allergy (hay fever) remedies experiences polarising trends in 2021
  • Australians remain prepared to tackle various health concerns
  • Despite challenging market conditions, Johnson & Johnson retains leadership of cough, cold and allergy (hay fever) remedies in 2021

PROSPECTS AND OPPORTUNITIES
  • Technological breakthrough with influenza vaccine likely to impact demand for cough, cold and allergy (hay fever) remedies
  • Segmentation as a strategy to add value
  • Climate to maintain demand for antihistamines/allergy remedies (systemic) over the forecast period

CATEGORY DATA
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
  • Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
  • Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026

DIGESTIVE REMEDIES IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Ageing demographic contributes to demand for digestive remedies
  • Greater alcohol intake as a result of the pandemic supports demand for antacids
  • Johnson & Johnson retains leadership of digestive remedies with wide product portfolio

PROSPECTS AND OPPORTUNITIES
  • Positive performance predicted for digestive remedies to be supported by prevailing trends including ageing population
  • Threat of substitution from probiotic supplements over the forecast period as Australians look to prevention over cure
  • Slower rate of decline for H2 blockers but Australians now rely on alternatives

CATEGORY DATA
  • Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
  • Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
  • Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
  • Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
  • Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
  • Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026

DERMATOLOGICALS IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Demand for dermatologicals starts to stabilise following 2020’s stockpiling
  • Atopic dermatitis and seborrheic dermatitis sufferers benefit from switch of mometasone furoate
  • Dermatologicals remains highly fragmented competitive landscape in Australia

PROSPECTS AND OPPORTUNITIES
  • Negative side effects of hand sanitisers may trigger new product development
  • Ongoing impact of COVID-19 on consumers’ psychological wellbeing will drive demand for hair loss treatments
  • Ageing population another contributing factor to growth of dermatologicals

CATEGORY DATA
  • Table 30 Sales of Dermatologicals by Category: Value 2016-2021
  • Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
  • Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
  • Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
  • Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
  • Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
  • Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026

NRT SMOKING CESSATION AIDS IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • COVID-19 health trends continue to encourage Australians to quit smoking
  • Australians adopt different methods to support their attempts to quit, including digital apps
  • Nicorette maintains its dominance due to wide availability and strong reputation

PROSPECTS AND OPPORTUNITIES
  • Technological advances within NRT smoking cessation aids and quitting apps set to drive new product developments over the forecast period
  • Long-term downward trend in tobacco smoking to slow growth of NRT smoking cessations aids over the forecast period

CATEGORY INDICATORS
  • Table 37 Number of Smokers by Gender 2016-2021

CATEGORY DATA
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
  • Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
  • Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
  • Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
  • Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026

SLEEP AIDS IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Positive growth by sleep aids supported by melatonin switch
  • Mental health issues to strengthen reliance on sleep aids post-pandemic
  • Dozile retains convincing leadership, but new entry melatonin-based Circadin gains ground

PROSPECTS AND OPPORTUNITIES
  • Solid demand for sleep aids over the forecast period
  • Herbal/traditional products expected to contribute to continued growth
  • Polarising trends for growth of sleep aids over the forecast period

CATEGORY DATA
  • Table 44 Sales of Sleep Aids: Value 2016-2021
  • Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
  • Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
  • Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
  • Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
  • Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026

EYE CARE IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Novelty of being able to leave the home boosts outdoor activities, supporting demand for allergy care
  • Work from home arrangements continue in Australia, positively impacting standard eye care
  • Eye care remains consolidated competitive landscape

PROSPECT AND OPPORTUNITIES
  • Remote working trend to ease over forecast period, hampering growth of standard eye care
  • Rapidly evolving developments within vision science have potential to hamper longer-term growth of standard eye care
  • Stronger performance for allergy eye care due to the longer allergy season and rising allergen levels

CATEGORY DATA
  • Table 50 Sales of Eye Care by Category: Value 2016-2021
  • Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
  • Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
  • Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
  • Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
  • Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026

WOUND CARE IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Return to low undynamic growth rates for wound care in 2021 as Australians use accumulated stock
  • Mature category needs innovation to drive value
  • Elastoplast and Band-Aid remain popular trusted wound care brands

PROSPECTS AND OPPORTUNITIES
  • Ageing population to stimulate demand for wound care over forecast period
  • Rising number of diabetes patients in Australia contributing factor to demand
  • Offering innovative products with natural positioning could offer stronger value growth potential

CATEGORY DATA
  • Table 56 Sales of Wound Care by Category: Value 2016-2021
  • Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
  • Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
  • Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
  • Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
  • Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026

VITAMINS IN AUSTRALIAHEADLINES
PROSPECTS
  • Challenging environment for companies competing within vitamins
  • COVID-19 challenges leading position of health and beauty specialist retailers as preferred channel of distribution for vitamins
  • New products and the rise of “purpose-driven” businesses

PROSPECTS AND OPPORTUNITIES
  • Further mergers and acquisitions, and brand extensions likely
  • Immunity for the longer-term
  • Personalisation and subscription services

CATEGORY DATA
  • Table 62 Sales of Vitamins by Category: Value 2016-2021
  • Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
  • Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
  • Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
  • Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
  • Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
  • Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026

DIETARY SUPPLEMENTS IN AUSTRALIAHEADLINES
PROSPECTS
  • Marketing the benefits of dietary supplements
  • Personalisation and subscription services.
  • Private label set to expand in fragmented competitive landscape

PROSPECTS AND OPPORTUNITIES
  • COVID-19 fast-tracks the use of technology
  • New products and the rise of “purpose-driven” businesses
  • Competition from functional foods

CATEGORY DATA
  • Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
  • Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
  • Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
  • Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
  • Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
  • Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
  • Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026

WEIGHT MANAGEMENT AND WELLBEING IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Trend towards healthy, home-cooked meals hampers growth of meal replacement
  • Supplement nutrition drinks remains only positive performer in 2021
  • Herbalife retains overall leadership, while Abbott Australasia continues to gain significant ground in supplement nutrition drinks

PROSPECTS AND OPPORTUNITIES
  • Obesity rates in Australia expected to contribute to improving demand for OTC obesity over course of forecast period
  • Holistic approach to food to further reduce reliance on weight management
  • Supplement nutrition drinks to remain strongest performer

CATEGORY DATA
  • Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
  • Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
  • Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
  • Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
  • Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026

SPORTS NUTRITION IN AUSTRALIAHEADLINES
PROSPECTS
  • Stable demand for sports nutrition in 2021 as health-conscious Australians continue to follow fitness regimes
  • Changing regulations for some sports nutrition products
  • Musashi remains dynamic performer in highly fragmented competitive landscape

PROSPECTS AND OPPORTUNITIES
  • Positive performance for sports nutrition as Australians return to regular exercise as part of healthy lifestyles
  • Sports nutrition to increasingly push boundaries
  • Chemist Warehouse strengthens sports nutrition with INC Protein

CATEGORY DATA
  • Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
  • Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
  • Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
  • Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
  • Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
  • Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026

HERBAL/TRADITIONAL PRODUCTS IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Solid performance for herbal/traditional products due to consumers’ positive perception
  • Dynamic growth despite challenges posed by COVID-19
  • Strong presence of local brands in highly fragmented competitive landscape

PROSPECTS AND OPPORTUNITIES
  • Shifting demographics continue to have a profound impact on growth
  • Search for natural options by Australian parents

CATEGORY DATA
  • Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
  • Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
  • Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
  • Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
  • Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026

PAEDIATRIC CONSUMER HEALTH IN AUSTRALIAHEADLINES
2021 DEVELOPMENTS
  • Limited growth for paediatric cough, cold and allergy remedies in 2021
  • COVID-19 has positive ripple effect on value growth for paediatric analgesics
  • Pharmacare Laboratories maintains convincing leadership

PROSPECTS AND OPPORTUNITIES
  • New product development in paediatric consumer health has potential to drive demand over forecast period
  • Stronger growth opportunities may be limited due to predicted stagnant birth rates

CATEGORY DATA
  • Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
  • Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
  • Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
  • Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
  • Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
  • Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026